Literature DB >> 28444154

Infectivity of an Asymptomatic Patient With Middle East Respiratory Syndrome Coronavirus Infection.

Soo-Youn Moon1, Jun Seong Son1.   

Abstract

During the MERS outbreak in Korea, one case of asymptomatic or mild MERS-CoV infection was noted. Eighty-two persons were exposed to the case without protection. They were isolated and RT-PCR and serology for MERS were performed. There was no transmission through an asymptomatic MERS case in this study.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  MERS; asymptomatic; infection.

Mesh:

Substances:

Year:  2017        PMID: 28444154      PMCID: PMC7108064          DOI: 10.1093/cid/cix170

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


Following the first Middle East respiratory syndrome (MERS)–coronavirus (MERS-CoV) infection in May 2015, there was a large outbreak in Korea with 186 laboratory-confirmed MERS-CoV infections that included 36 fatalities [1]. Asymptomatic or mild cases of MERS-CoV infection have been noted in Saudi Arabia [2, 3], and during the MERS outbreak, 1 case of asymptomatic or mild symptomatic MERS-CoV infection was noted in Korea. There are little data on the infectivity of those asymptomatic or mild MERS-CoV infections, and in this study, we investigated the infectivity of an asymptomatic or mild patient with MERS-CoV infection.

METHODS

On June 2015, MERS-CoV infection was confirmed in a healthcare provider (HCP) without symptoms of MERS at a university hospital, where MERS-CoV infected patients were hospitalized. A nurse was isolated for 2 weeks after contacting the hemodialysis patient with confirmed MERS without proper personal protective equipment (PPE). After the isolation, real-time reverse transcriptase polymerase chain reaction (RT-PCR) for MERS-CoV was done for surveillance prior to returning to work. The result of RT-PCR test reported after 36 hours was positive, but she had no symptoms. During the 36 hours, she continued her work and might have inadvertently exposed coworkers to MERS-CoV. But until PCR result was available, she did not contact the patients. All the HCPs that had contact with the asymptomatic MERS-CoV positive nurse without proper PPE were isolated at home for 2 weeks, and their contact was graded according to timing and closeness of the contact [4]. A grade 1 contact meant that the person contacted the index patient directly or stayed within 2 meters from the index patient and without having personal protective equipment. A grade 2 contact was for the person staying in the same space of 2 meters or more, separated from index patient, but without personal protective equipment. A grade 3 contact had the person staying in the same space of the index patient at different times without personal protective equipment, and possibly contacting the patient indirectly. The symptoms of these persons were monitored by daily telephone. When the isolated person reported symptoms possibly related to MERS, RT-PCR was performed. At the end of the isolation period, RT-PCR for MERS-CoV was performed for surveillance for all 82 healthcare worker (HCWs) before returning to work. DiaPlexQTM MERS Virus Detection Kit II (SolGent, Korea), targeting 3 genes (upE, ORF1a, and ORF1b) was used for RT-PCR. Blood samples were collected for a serologic test for MERS at 2 and 4 weeks after the exposure and for those who consented to the test. We performed an enzyme-linked immunosorbent assay (ELISA) (Euroimune, Lübeck, Germany) to screen for the presence of MERS-CoV immunoglobulin G (IgG). When the optical density of ELISA exceeded cut-off value of >50% of the reference, an indirect immunofluorescence test (IIFT) (euroimmun) was performed to confirm MERS-CoV IgG and quantify antibody titers. Serum was diluted 100-fold, according to the protocol suggested by the manufacturer. Antibody titer measurement was conducted by 2-fold dilution from 1:100 to 1:3200.

RESULTS

For 36 hours, 82 HCWs had contact with the asymptomatic or mildly symptomatic but MERS-CoV positive HCW. All 82 HCWs were isolated at home for 2 weeks. The mean age of these workers was 34.5 ± 11.1 years, and 34.1% of them were male. There were 33 HCWs with grade 1 contact (40.2%), 30 HCWs with grade 2 contact (36.6%), and 19 HCWs with grade 3 contact (23.2%) (Table 1).
Table 1.

Characteristics of the HCWs

No. of patients (%)
Age34.5 ± 11.1
Male sex28 (34.1)
Grade of contact
 Grade 133 (40.2)
 Grade 230 (36.6)
 Grade 319 (23.2)
Symptoms4 (4.9)
Negative RT-PCR for MERS82 (100.0)
Negative serology for MERS45/45 (100.0)

Abbreviations: HCW, healthcare worker; MERS, Middle East respiratory syndrome; RT-PCR, reverse transcriptase polymerase chain reaction.

Characteristics of the HCWs Abbreviations: HCW, healthcare worker; MERS, Middle East respiratory syndrome; RT-PCR, reverse transcriptase polymerase chain reaction. During the isolation, 4 HCWs had symptoms possibly related to MERS. One person had mild diarrhea, another had diarrhea and rhinorrhea, 1 had some mucus in throat, and 1 had dyspnea and sore throat. Three of them had grade 1 contact with the index person without personal protective equipment. RT-PCR tests during those symptoms were all negative. The results of surveillance RT-PCR for MERS at the end of isolation were negative for all 82 HCWs. Serology for MERS was done for 45 persons, and the results were all negative.

CONCLUSIONS

MERS is known to be transmitted by droplet, contact, and airborne spread among humans [5]. Clinical symptoms of MERS rage from asymptomatic infection to severe pneumonia with acute respiratory distress syndrome, resulting in death [6]. Asymptomatic infections have been detected previously [2, 3, 7]. Although many patients have had severe disease, some reports have described individuals with a mild respiratory illness as not requiring hospitalization [8, 9]. A nationwide serological study in Saudi Arabia showed that anti-MERS-CoV antibodies were confirmed in 0.15% of the general population with seroprevalence of MERS-CoV antibodies being significantly higher in shepherds (2.3%) and slaughterhouse workers (3.6%) [10]. It is possible that there were some asymptomatic or mild cases during the MERS outbreak. It appears that many individuals who have been reported as being asymptomatic even though they had some signs and symptoms. In a study of the healthcare facility associated with the outbreak in Jeddah, Saudi Arabia, there were 64 cases of 255 laboratory-confirmed cases of MERS initially thought to be asymptomatic [2]. But among the 64 asymptomatic patients, 33 patients were interviewed and 26 patients (79%) reported at least 1 symptom consistent with a viral respiratory illness [2]. It is also not clear whether asymptomatic infection can lead to transmission between humans, although there is 1 study showing possible nosocomial infection through asymptomatic or mild case in Saudi Arabia [7]. During the MERS outbreak in Korea, there were cases without an obvious origin of infection. It is possible that these cases were linked to asymptomatic or mild cases. To make effective precautionary measures against transmission, knowing the transmission mode and clinical features of all MERS cases is necessary. In particular, the infectivity of asymptomatic or mild MERS cases is an important factor to consider in quarantine measures. In cases of asymptomatic or mild MERS, it is quite difficult to identify the contact persons and the outcome of the contact. In this case report, we could identify the asymptomatic or mild MERS case by surveillance RT-PCR. We could also identify those who contacted the asymptomatic or mild MERS case and follow them for 2 weeks. In this study, there was no transmission by asymptomatic MERS infection. But more data should be collected to confirm the infectivity of the asymptomatic or mild case of MERS.
  10 in total

1.  Middle East respiratory syndrome coronavirus infections in health care workers.

Authors:  Ziad A Memish; Alimuddin I Zumla; Abdullah Assiri
Journal:  N Engl J Med       Date:  2013-08-07       Impact factor: 91.245

2.  2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.

Authors:  Ikwo K Oboho; Sara M Tomczyk; Ahmad M Al-Asmari; Ayman A Banjar; Hani Al-Mugti; Muhannad S Aloraini; Khulud Z Alkhaldi; Emad L Almohammadi; Basem M Alraddadi; Susan I Gerber; David L Swerdlow; John T Watson; Tariq A Madani
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

3.  Middle East respiratory syndrome: A new global threat.

Authors:  Pradeep Kumar Bhatia; Priyanka Sethi; Neeraj Gupta; Ghansham Biyani
Journal:  Indian J Anaesth       Date:  2016-02

Review 4.  Middle East respiratory syndrome.

Authors:  Alimuddin Zumla; David S Hui; Stanley Perlman
Journal:  Lancet       Date:  2015-06-03       Impact factor: 79.321

5.  A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker.

Authors:  Manal Al-Gethamy; Victor M Corman; Raheela Hussain; Jaffar A Al-Tawfiq; Christian Drosten; Ziad A Memish
Journal:  Clin Infect Dis       Date:  2014-12-16       Impact factor: 9.079

6.  Middle East Respiratory Syndrome Coronavirus Transmission in Dialysis Unit and Infection Control Interventions in Korea.

Authors:  Soo-Youn Moon; Jun Seong Son; Yu Ho Lee; Young-Tae Kwak; Ho Yeon Chung; Hyung-Lae Lee; Woo-In Lee; Sang Ho Lee; Ju-Young Moon; Yang-Gyun Kim
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

7.  Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.

Authors:  Marcel A Müller; Benjamin Meyer; Victor M Corman; Malak Al-Masri; Abdulhafeez Turkestani; Daniel Ritz; Andrea Sieberg; Souhaib Aldabbagh; Berend-J Bosch; Erik Lattwein; Raafat F Alhakeem; Abdullah M Assiri; Ali M Albarrak; Ali M Al-Shangiti; Jaffar A Al-Tawfiq; Paul Wikramaratna; Abdullah A Alrabeeah; Christian Drosten; Ziad A Memish
Journal:  Lancet Infect Dis       Date:  2015-04-08       Impact factor: 25.071

8.  Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015.

Authors:  Myoung-don Oh; Pyoeng Gyun Choe; Hong Sang Oh; Wan Beom Park; Sang-Min Lee; Jinkyeong Park; Sang Kook Lee; Jeong-Sup Song; Nam Joong Kim
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

9.  Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Dromedaries Imported from Oman to United Arab Emirates, May 2015.

Authors:  Zulaikha M Al Hammadi; Daniel K W Chu; Yassir M Eltahir; Farida Al Hosani; Mariam Al Mulla; Wasim Tarnini; Aron J Hall; Ranawaka A P M Perera; Mohamed M Abdelkhalek; J S M Peiris; Salama S Al Muhairi; Leo L M Poon
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883

10.  A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case.

Authors:  Ali S Omrani; Mohammad Abdul Matin; Qais Haddad; Daifullah Al-Nakhli; Ziad A Memish; Ali M Albarrak
Journal:  Int J Infect Dis       Date:  2013-08-02       Impact factor: 3.623

  10 in total
  15 in total

1.  Risk Assessment for the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) on Aircraft: A Systematic Review.

Authors:  T Berruga-Fernández; E Robesyn; T Korhonen; P Penttinen; J M Jansa
Journal:  Epidemiol Infect       Date:  2021-06-10       Impact factor: 2.451

Review 2.  An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Viruses       Date:  2017-12-02       Impact factor: 5.048

Review 3.  Host Determinants of MERS-CoV Transmission and Pathogenesis.

Authors:  W Widagdo; Syriam Sooksawasdi Na Ayudhya; Gadissa B Hundie; Bart L Haagmans
Journal:  Viruses       Date:  2019-03-19       Impact factor: 5.048

4.  Transmissibility of MERS-CoV Infection in Closed Setting, Riyadh, Saudi Arabia, 2015.

Authors:  Maria D Van Kerkhove; Sadoof Alaswad; Abdullah Assiri; Ranawaka A P M Perera; Malik Peiris; Hassan E El Bushra; Abdulaziz A BinSaeed
Journal:  Emerg Infect Dis       Date:  2019-10-17       Impact factor: 6.883

5.  Middle East respiratory syndrome coronavirus transmission among health care workers: Implication for infection control.

Authors:  Sarah H Alfaraj; Jaffar A Al-Tawfiq; Talal A Altuwaijri; Marzouqa Alanazi; Nojoom Alzahrani; Ziad A Memish
Journal:  Am J Infect Control       Date:  2017-09-25       Impact factor: 2.918

6.  Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review.

Authors:  Jaffar A Al-Tawfiq; Philippe Gautret
Journal:  Travel Med Infect Dis       Date:  2018-12-11       Impact factor: 6.211

7.  The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.

Authors:  Yu Han; Hailan Yang
Journal:  J Med Virol       Date:  2020-03-12       Impact factor: 2.327

8.  Infectious MERS-CoV Isolated From a Mildly Ill Patient, Saudi Arabia.

Authors:  Hail M Al-Abdely; Claire M Midgley; Abdulrahim M Alkhamis; Glen R Abedi; Azaibi Tamin; Alison M Binder; Khalid Alanazi; Xiaoyan Lu; Osman Abdalla; Senthilkumar K Sakthivel; Mutaz Mohammed; Krista Queen; Homoud S Algarni; Yan Li; Suvang Trivedi; Abdullah Algwizani; Raafat F Alhakeem; Natalie J Thornburg; Suxiang Tong; Sameeh S Ghazal; Dean D Erdman; Abdullah M Assiri; Susan I Gerber; John T Watson
Journal:  Open Forum Infect Dis       Date:  2018-05-15       Impact factor: 3.835

9.  Middle East Respiratory Syndrome Coronavirus and the One Health concept.

Authors:  Maged Gomaa Hemida
Journal:  PeerJ       Date:  2019-08-22       Impact factor: 2.984

Review 10.  Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature.

Authors:  J A Al-Tawfiq; P G Auwaerter
Journal:  J Hosp Infect       Date:  2018-06-01       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.